Bone Metastases: A Translational And Clinical Approach by Vassilios VassiliouBone Metastases: A Translational And Clinical Approach by Vassilios Vassiliou

Bone Metastases: A Translational And Clinical Approach

byVassilios VassiliouEditorEdward Chow, Dimitrios Kardamakis

Paperback | September 17, 2016

Pricing and Purchase Info

$210.74 online 
$220.95 list price
Earn 1,054 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

Title:Bone Metastases: A Translational And Clinical ApproachFormat:PaperbackDimensions:490 pages, 23.5 × 15.5 × 0.02 inPublished:September 17, 2016Publisher:Springer NatureLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:9402405003

ISBN - 13:9789402405002

Look for similar items by category:

Reviews

Table of Contents

Preface. IFUNDAMENTAL CONCEPTS.1 Pathophysiology of metastatic bone disease. 2 Bone metastases: epidemiology, clinical picture, SREs and prognosis. 3 Pain in bone metastases: types and mechanisms. IIINVESTIGATIONS OF BONE METASTASES. 4 Radiological evaluations: radiography, CT, MRI. 5 Nuclear medicine imaging modalities: bone scintigraphy, PET-CT, SPECT. 6. Bone turnover markers. 7. New omics approaches for bone metastases. IIITHERAPEUTIC MANAGEMENT. 8 Analgesic treatment for bone mets. 9. Radiotherapy: external beam and radio-surgery. 10 Radionuclide therapy.11. Bisphosphonates. 12 New targeted therapies for bone metastases. 13. Chemotherapy and hormone therapy. 14 HIFU/Radioablation. 15 Neuropathic bone metastases. 16. Spinal cord compression and cauda equina compression. 17 Pathological and impending fracture. 18 Re-irradiation. 19. Bone metastases in elderly patients. 20. Management of metastatic bone disease in the elderly with bisphosphonates and RANKL inhibitors: effectiveness and safety. IVASSESMENT OF THERAPEUTIC RESPONSE. 21 Radiological and nuclear medicine imaging modalities. 22 Clinical assessment measures. 23 Outcome measures in bone metastases clinical trials. 24 Quality of life in patients suffering from metastatic skeletal disease. VCOST OF MANAGING METASTATIC BONE DISEASE. 25 Cost effectiveness of treatment modalities for bone metastases. Index.